F. Karakuş Et Al. , "Exploring Natural Compounds Targeting PD-L1 and STAT3:Toxicogenomic Analysis, Virtual Screening, Molecular Docking,ADMET Evaluation, and Biological Activity Prediction," CURRENT COMPUTER-AIDED DRUG DESIGN , 2024
Karakuş, F. Et Al. 2024. Exploring Natural Compounds Targeting PD-L1 and STAT3:Toxicogenomic Analysis, Virtual Screening, Molecular Docking,ADMET Evaluation, and Biological Activity Prediction. CURRENT COMPUTER-AIDED DRUG DESIGN .
Karakuş, F., Kuzu, B., Köstekci, S., & Tülüce, Y., (2024). Exploring Natural Compounds Targeting PD-L1 and STAT3:Toxicogenomic Analysis, Virtual Screening, Molecular Docking,ADMET Evaluation, and Biological Activity Prediction. CURRENT COMPUTER-AIDED DRUG DESIGN .
Karakuş, Fuat Et Al. "Exploring Natural Compounds Targeting PD-L1 and STAT3:Toxicogenomic Analysis, Virtual Screening, Molecular Docking,ADMET Evaluation, and Biological Activity Prediction," CURRENT COMPUTER-AIDED DRUG DESIGN , 2024
Karakuş, Fuat Et Al. "Exploring Natural Compounds Targeting PD-L1 and STAT3:Toxicogenomic Analysis, Virtual Screening, Molecular Docking,ADMET Evaluation, and Biological Activity Prediction." CURRENT COMPUTER-AIDED DRUG DESIGN , 2024
Karakuş, F. Et Al. (2024) . "Exploring Natural Compounds Targeting PD-L1 and STAT3:Toxicogenomic Analysis, Virtual Screening, Molecular Docking,ADMET Evaluation, and Biological Activity Prediction." CURRENT COMPUTER-AIDED DRUG DESIGN .
@article{article, author={Fuat Karakuş Et Al. }, title={Exploring Natural Compounds Targeting PD-L1 and STAT3:Toxicogenomic Analysis, Virtual Screening, Molecular Docking,ADMET Evaluation, and Biological Activity Prediction}, journal={CURRENT COMPUTER-AIDED DRUG DESIGN}, year=2024}